Synthesis of Novel Pyrido[1,2- c ]pyrimidine Derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole Moiety as Potential SSRI and 5-HT 1A Receptor Ligands

Two series of novel 4-aryl-2H-pyrido[1,2-c]pyrimidine (6a-i) and 4-aryl-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine ( ) derivatives were synthesized. The chemical structures of the new compounds were confirmed by H and C NMR spectroscopy and ESI-HRMS spectrometry. The affinities of all compounds for t...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 22; no. 5
Main Authors Król, Marek, Ślifirski, Grzegorz, Kleps, Jerzy, Ulenberg, Szymon, Belka, Mariusz, Bączek, Tomasz, Siwek, Agata, Stachowicz, Katarzyna, Szewczyk, Bernadeta, Nowak, Gabriel, Duszyńska, Beata, Herold, Franciszek
Format Journal Article
LanguageEnglish
Published Switzerland 26.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two series of novel 4-aryl-2H-pyrido[1,2-c]pyrimidine (6a-i) and 4-aryl-5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine ( ) derivatives were synthesized. The chemical structures of the new compounds were confirmed by H and C NMR spectroscopy and ESI-HRMS spectrometry. The affinities of all compounds for the 5-HT receptor and serotonin transporter protein (SERT) were determined by in vitro radioligand binding assays. The test compounds demonstrated very high binding affinities for the 5-HT receptor of all derivatives in the series ( and ) and generally low binding affinities for the SERT protein, with the exception of compounds and . Extended affinity tests for the receptors D , 5-HT , 5-HT and 5-HT were conducted with regard to selected compounds ( , , and ). All four compounds demonstrated very high affinities for the D and 5-HT receptors. Compounds and also had high affinities for 5-HT , while and held moderate affinities for this receptor. Compounds and were also tested in vivo to identify their functional activity profiles with regard to the 5-HT receptor, with demonstrating the activity profile of a presynaptic agonist. Metabolic stability tests were also conducted for and .
ISSN:1422-0067